A China-oriented fund could may be joining Veritas's sole Chilean offering, managed by Ezra Sun, which has raised USD 1 billion.
Local advisors witness asset shift abroad amid Chilean unrest
Multi-family offices and the HNW segments of local banks have followed large family offices in moving wealth outside the country, advisors told Fund Pro Latin America.
CCR Monthly Approval Report – January 2020
Lazard, Credicorp Capital, Franklin Templeton, Pictet, Aditya Birla Sun Life, Altamar, Golden Gate, CarVal Investors, Golub, Kayne Anderson and Monarch were the managers registering products in January 2020.
CCR Monthly Approval Report – December 2019
SEI and LFDE, La Financière de l'Echiquier, led the list of registered investment products with five and three mutual funds, respectively, followed by Morgan Stanley and Wellington each with one product approved.
CCR lowers bar for alternatives managers seeking approval
Alternatives managers no longer need to show a USD 5 billion allocation in a specific asset class in order to gain CCR approval to sell to AFPs.
Picton closes the year with a recognition and regional presence
Picton has signed mandates with firms like KKR, TPG, Ares, American Securities, Hamilton Lane, EQT, Permira and Apollo, among others.
Chilean AFPs poured into Asian equity in November while continuing to cut fixed-income
The AFPs finished November with USD 82 billion invested in cross-border funds and ETFs, 73% of which was in equities.
Peruvian real-estate providers pounce on Chilean market
The situation of the real estate market in Chile could make Peruvian products attractive, especially for high-net-worth investors, said Jenny Esaine, partner of AC Capitales.
CCR Monthly Approval Report – November 2019
PGIM, the global investment management business of Prudential Financial, WisdomTree, DWS, iShares, JPMorgan, Jupiter, Moneda, NN IP, Ossiam, State Street, Benefit Street Partners, Insight Partners, JPMorgan, New Mountain Capital, Park Square Capital and Värde Management were the fund sponsors gaining approval for new products.




